Algert Global LLC Roivant Sciences Ltd. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.36 - $11.74 $1.06 Million - $1.2 Million	-102,329 Reduced 68.83%	46,331 $490,000
Q1 2024 May 14, 2024	SELL	$9.87 - $11.8 $450,249 - $538,292	-45,618 Reduced 23.48%	148,660 $1.57 Million
Q4 2023 Feb 14, 2024	BUY	$8.38 - $11.58 $685,718 - $947,568	81,828 Added 72.77%	194,278 $2.18 Million
Q3 2023 Nov 13, 2023	BUY	$9.76 - $13.19 $1.1 Million - $1.48 Million	112,450 New	112,450 $1.31 Million

311

508M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.95B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.